EG18175A - Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctions - Google Patents

Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctions

Info

Publication number
EG18175A
EG18175A EG18087A EG18087A EG18175A EG 18175 A EG18175 A EG 18175A EG 18087 A EG18087 A EG 18087A EG 18087 A EG18087 A EG 18087A EG 18175 A EG18175 A EG 18175A
Authority
EG
Egypt
Prior art keywords
prophylaxis
treatment
compounds
preparing
agents containing
Prior art date
Application number
EG18087A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of EG18175A publication Critical patent/EG18175A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Epoxy Compounds (AREA)
EG18087A 1986-03-27 1987-03-25 Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctions EG18175A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863610391 DE3610391A1 (de) 1986-03-27 1986-03-27 Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen

Publications (1)

Publication Number Publication Date
EG18175A true EG18175A (en) 1994-07-30

Family

ID=6297417

Family Applications (1)

Application Number Title Priority Date Filing Date
EG18087A EG18175A (en) 1986-03-27 1987-03-25 Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctions

Country Status (25)

Country Link
EP (1) EP0243645B1 (xx)
JP (1) JPS62240698A (xx)
KR (1) KR870008841A (xx)
CN (1) CN1031267C (xx)
AT (1) ATE102954T1 (xx)
AU (1) AU621278B2 (xx)
CA (1) CA1341064C (xx)
CS (2) CS651989A3 (xx)
DD (1) DD280765A5 (xx)
DE (2) DE3610391A1 (xx)
DK (1) DK172221B1 (xx)
EG (1) EG18175A (xx)
ES (1) ES2061447T3 (xx)
FI (1) FI91876C (xx)
HU (2) HU203117B (xx)
IE (1) IE62456B1 (xx)
MA (1) MA20919A1 (xx)
NO (1) NO178546C (xx)
NZ (1) NZ219764A (xx)
OA (1) OA08506A (xx)
PH (1) PH27210A (xx)
PT (1) PT84564B (xx)
RU (1) RU1836335C (xx)
TN (1) TNSN87045A1 (xx)
ZA (1) ZA872230B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
AU612137B2 (en) * 1987-04-27 1991-07-04 E.R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing an ace inhibitor
DE3731085A1 (de) * 1987-09-16 1989-04-06 Hoechst Ag Neue aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
DE3801587A1 (de) * 1988-01-21 1989-08-03 Hoechst Ag Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
EP0331609A3 (de) * 1988-01-27 1992-07-01 Hoechst Aktiengesellschaft Angiotensin-Converting-Enzym-Hemmstoffe mit psychotroper Wirkung
DE3803225A1 (de) * 1988-02-04 1989-08-17 Hoechst Ag Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
US5037821A (en) * 1988-06-01 1991-08-06 E. R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor
US5093129A (en) * 1989-01-30 1992-03-03 E. R. Squibb & Sons, Inc. Method for treating addiction to a drug of abuse employing an ace inhibitor
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
JP2004532200A (ja) * 2001-03-15 2004-10-21 サエジス ファーマシューティカルズ， インコーポレイテッド 全身性ストレスの後に認識機能を回復するための方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19575012I2 (de) * 1980-10-23 2002-01-24 Schering Corp Carboxyalkyl-Dipeptide Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3300774A1 (de) * 1983-01-12 1984-07-12 Hoechst Ag, 6230 Frankfurt Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung

Also Published As

Publication number Publication date
CS212687A3 (en) 1992-04-15
NZ219764A (en) 1990-11-27
PT84564B (pt) 1989-11-10
HU896609D0 (en) 1990-02-28
ES2061447T3 (es) 1994-12-16
NO871282L (no) 1987-09-28
EP0243645A2 (de) 1987-11-04
DE3789330D1 (de) 1994-04-21
DK153587D0 (da) 1987-03-26
ZA872230B (en) 1987-09-21
AU7064987A (en) 1987-10-01
IE62456B1 (en) 1995-02-08
OA08506A (fr) 1988-07-29
NO871282D0 (no) 1987-03-26
CS276385B6 (en) 1992-05-13
FI871304A (fi) 1987-09-28
CN1031267C (zh) 1996-03-13
DK172221B1 (da) 1998-01-12
HU202118B (en) 1991-02-28
KR870008841A (ko) 1987-10-21
MA20919A1 (fr) 1987-10-01
CA1341064C (en) 2000-08-01
IE870784L (en) 1987-09-27
JPS62240698A (ja) 1987-10-21
ATE102954T1 (de) 1994-04-15
CS276179B6 (en) 1992-04-15
CS651989A3 (en) 1992-05-13
DD280765A5 (de) 1990-07-18
NO178546B (no) 1996-01-08
PH27210A (en) 1993-05-04
RU1836335C (ru) 1993-08-23
EP0243645B1 (de) 1994-03-16
HU203117B (en) 1991-05-28
NO178546C (no) 1996-04-17
EP0243645A3 (en) 1990-01-24
FI871304A0 (fi) 1987-03-25
CN87102304A (zh) 1987-12-30
PT84564A (de) 1987-04-01
TNSN87045A1 (fr) 1990-01-01
FI91876C (fi) 1994-08-25
FI91876B (fi) 1994-05-13
AU621278B2 (en) 1992-03-12
DK153587A (da) 1987-09-28
DE3610391A1 (de) 1987-10-08
HUT46046A (en) 1988-09-28

Similar Documents

Publication Publication Date Title
HUT43582A (en) Process for production of derivatives of 4,5,6-substituated-n-/substituated phenil/-piramidin-amin and medical compounds containing thereof
GR860571B (en) Labdan-derivatives process for their preparation and their use as medicaments
EG18175A (en) Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctions
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
ZA8996B (en) Chemical compounds
IL89031A0 (en) Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation
ES8607916A1 (es) Un procedimiento para la preparacion de medicamentos influenciadores de la circulacion sanguinea, que contienen compuestos de bis (carboxamida)
PH24568A (en) Use of bezafibrate for treating diabetes
PT82202A (en) Process for the preparation of polyprenyl compounds
EP0257631A3 (en) Oxolabdanes, a process for their preparation and their use as medicaments
JO1516B1 (en) Compounds with cognitive effectiveness, factors containing them, and their use in treatment and disease prevention for cognitive dysfunction
MTP1001B (en) Compounds having a cognition adjuvant action,agents containing them,and the use of there of for treatment and prophylaxis of cognitive dysfunctions (hoe 86/f069)
GR3006610T3 (xx)
YU137985A (en) Process for treatment of used catalyzer containing vanadium